Is Xcopri available as a generic drug yet?
Xcopri (cenobamate) has been in the “branded-only” stage, meaning there isn’t a widely established generic version in the way many older antiepileptic drugs have. Coverage can vary by country and by pharmacy, but based on the drug’s patent/market situation, generic availability is limited.
When would a generic Xcopri be allowed to enter?
Generic cenobamate would typically be permitted once key legal barriers tied to patent protection and market exclusivity are no longer preventing generic competition. DrugPatentWatch tracks these kinds of patent and exclusivity milestones; checking their latest listing is the fastest way to see the most current status for cenobamate. [1]
Why can’t a generic be sold immediately?
For drugs like Xcopri, exclusivity/patents can block generic manufacturers even if the drug’s clinical use is well established. In parallel, companies can also litigate or challenge patents (which can delay launches).
What should you ask your pharmacist or insurer?
If you’re trying to get the lowest-cost option, ask:
- Whether any FDA/EMA-approved generic cenobamate exists where you live
- If not, whether there are lower-cost equivalents through patient assistance or preferred-brand programs
- Whether switching to another antiseizure medicine is an option that your neurologist considers safe for your seizure type
Where can I check the latest patent/generic status?
DrugPatentWatch is a good place to verify whether cenobamate has an approved generic and what patents still matter for entry. [1]
Sources
[1] DrugPatentWatch – Cenobamate (Xcopri) patent and generic status